Ophthalmic Adaptive Optics (AO) Retinal Imaging System
Posted Date:
Jun 02, 2026
Jun 16, 2026
Awarded Date:
No Awarded Date
| SetAside Type | ||
| Total Small Business Set-Aside (FAR 19.5) | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| RFQ-FDA-133666 | Ophthalmic Adaptive Optics (AO) Retinal Imaging System | |
| Synopsis | ||
|
The Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), Office of Science and Engineering Laboratories (OSEL), Division of Biomedical Physics (DBP) intends to acquire one (1) Ophthalmic Adaptive Optics (AO) Retinal Imaging System. The system will be used to support retinal imaging research, biomarker development, and regulatory science activities at the FDA White Oak Campus in Silver Spring, Maryland. Delivery and installation shall be made to 10903 New Hampshire Avenue, Building WO62, Room G101, Silver Spring, MD 20993. For complete requirements, terms, and conditions, please refer to the attached Combined Synopsis/Solicitation (CSS) document No. RFQ-FDA-133666 . .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| FOOD AND DRUG ADMINISTRATION | Combined Synopsis/Solicitation | |
